A B S T R A C T The correlation between the incidence and level of immune complexes in serum and synovial fluid and the various clinical and biological manifestations of rheumatoid arthritis has been studied. Immune complexes were quantitated using a sensitive radioimmunoassay, the "I-Clq binding test, in unheated native sera and synovial fluids from 50 patients with seropositive (RA +) and 45 with seronegative (RA -) rheumatoid arthritis, 17 with other inflammatory arthritis, and 37 with degenerative and post-traumatic joint disease. The following observations were made: (a) when compared to the results from patients with degenerative and post-traumatic joint diseases, the l"I-Clq binding activity (Clq-BA) in synovial fluid was found to be increased (by more than 2 SD) in most of the patients with RA+ (80%) and RA-(71%) and in 29% of patients with other inflammatory arthritis; the serum Clq-BA was also frequently increased in both RA + (76%) and RA -(49%) patients, but only exceptionally in patients with other inflammatory arthritis (6%); (b) a significant negative correlation existed between the Clq-BA and the immunochemical C4 level in synovial fluids from patients with RA + and RA -; (c) neither the serum nor the synovial fluid Clq-BA in rheumatoid arthritis significantly correlated with the erythrocyte sedimentation rate, the clinical stage of the disease, or the IgM rheumatoid factor titer; and (d) the serum Clq-BA in patients with rheumatoid arthritis and extra-articular disease manifestations (40±34% in those with RA +, 32±29% in those with RA -)
INTRODUCTION
The evidence for the involvement of immune complexes in the pathogenesis of rheumatoid arthritis (RA)' is based on the direct demonstration of such complexes in the synovium (1, 2) or in the synovial fluid (3) (4) (5) , and on the observation of biological changes generally as-sociated with the formation of immune complexes such as an increased catabolism of complement components (6) (7) (8) (9) . Two major approaches were used in order to detect immune complexes in serum or in joint fluid. First, the existence of specific antigen-antibody systems was investigated and immunoglobulin-anti-immunoglobulin complexes were particularly demonstrated (4, 5, (10) (11) (12) (13) (14) (15) . Secondly, methods which are not specific for any particular antigen-antibody system were used. These studies were mostly qualitative and led to the demonstration of immune complex-like material such as cryoglobulins (16, 17) , macromolecular complexes (3, 10, 11) , Clq precipitins (4, 5) , complement fixing material (4, 16) , or of complexes reacting with monoclonal rheumatoid factor (5) . Recently, quantitative investigations were carried out using radioimmunological techniques such as for binding of complexes by rheumatoid factor (18, 19) and macrophages (20) . These studies have suggested a possible role of immune complexes in articular and extra-articular manifestations of RA.
The main purpose of this work was to define the correlation between the incidence and the level of immune complexes in serum and synovial fluid on one hand, and the various forms of clinical and biological manifestations of RA on the other. Immune complexes were quantitated in the sera and the synovial fluids from patients with various forms of arthritis, using a sensitive radioimmunoassay, the 'I-Clq binding test, which has been previously applied to the study of patients with systemic lupus erythematosus (21) and which has been recently modified for the detection of complexes in unheated native serum or synovial fluid samples (22) . These studies confirmed the presence of immune complexes in synovial fluid but also led to the demonstration of a high amount of immune complexes in serum. The Clq binding complexes have been further characterized physicochemically and immunochemically. These clinical investigations suggested that the use of such radioimmunoassays for immune complexes would be of practical value in the diagnosis and in follow up studies of RA. (24) . IgM rheumatoid factor was measured by the sensitized sheep cell agglutination technique (25) . RA patients were considered as seropositive when the rheumatoid factor titer was equal or higher than 1: 64. Nonrheumatoid patients satisfied generally accepted diagnostic criteria. Synovial fluids of 15 patients who suffered from post-traumatic joint effusions (7 with meniscus lesions, 7 with luxations or closed fractures, 1 with hydarthrosis) were used as controls for the other studies.
METHODS
Collection and storage of synovial fluid serum and plasma. Synovial fluids were collected mostly from the knee and only in some instances from the shoulder or elbow joints.
The samples were immediately mixed with EDTA (20 mM, final concentration) then centrifuged at 1,500 g for 15 min at room temperature. The supernates were immediately frozen and stored at -70'C in portions of 0.5 ml. For the collection of serum, blood was allowed to clot at room temperature for 60 min, was then centrifuged at 1,500 g for 15 min and the serum was stored at -70'C. To obtain plasma blood was collected in plastic tubes containing EDTA (20 mM final concentration), centrifuged at 1,500 g for 15 min, and the supernate was immediately stored at -700C.
".5I-Clq binding test. The basic principle of this test is outlined on Fig. 1 . For the present investigation, the technique was performed as follows (22) : Clq was isolated from fresh normal human serum (NHS) by the method of Volanakis and Stroud (26) , but relative salt concentrations of 0.04 and 0.078 M NaCI, respectively, were attained for the first and second precipitation steps. Radioiodination of Clq with lactoperoxydase was performed according to Heusser et al. (27) . The 'I-Clq had a sp act of 1 /sCi//Lg protein, and was stored in portions of 10 ,ug in 100 jul of barbital buffered saline (containing Ca and Mg) (VBS) (28) . On the day of testing, a portion of isolated labeled Clq was diluted in 3-5 ml VBS containing 1% (wt/vol) bovine serum albumin (A grade, Calbiochem, San Diego, Calif.) and centrifuged at 18,000 g for 40 min at 4VC in order to remove aggregated Clq. The supernate was used for the test. The test was carried out in duplicate, using Bio-Vial polypropylene tubes (Beckman Instruments, Inc., Palo Alto, Calif.). For testing of patients' sera, 50 Al of tested serum was mixed with 100 ul of Na2EDTA, 0.2 M, (adjusted to pH 7.5 with NaOH) and incubated for 30 min at 37°C. Then, the mixture was transferred into an ice bath. 50 1A1 of the '5I-Clq and 1 ml of 3% (wt/vol) PEG (polyethylene glycol) (DAB-7, mol wt 6,000, Siegfried, Zofingen, Switzerland) solution were added. PEG was dissolved in 0.1 M boric acid, 0.025 M di-sodium-tetraborate, 0.075 M NaCl, pH 8.3 . After the addition of PEG, the mixture was left on ice for 60 min and centrifuged at 1,500 g for 20 min at 4°C. The supernate was completely discarded and the radioactivity was measured on the precipitate. Results were expressed as percent 'I-Clq precipitated as compared with the radioactivity precipitated in a "trichloracetic acid control" tube in which 1 ml 20% trichloracetic acid was added to 100 8.3 . The mixture was kept at 4°C for 1 h, centrifuged at 2,000 g for 30 min, the precipitate was homogenized and resuspended with borate-EDTA buffer in one fifth of the original volume of synovial fluid.
Immunochemical techniques. Immunoabsorption: rabbit anti-human IgG (21) or bovine serum albumin were coupled to CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals, Inc., Uppsala, Sweden) according to the manufacturer's recommendation. Two identical 3 ml-(0.5 cm diameter) columns were prepared. The columns were washed with normal rabbit serum to decrease the nonspecific binding and were then equilibrated with borate-EDTA buffer, pH 8.3 at 4VC. Thereafter, 0.4 ml of Clq binding gradient fraction was applied to each column and the flow was stopped for 30 min. Serial fractions of 0.2 ml were eluted and tested for 'I-Clq BA.
Immunoelectrophoresis: gradient fractions were tested by the method of Scheidegger (31) using commercial rabbit antiwhole human serum and rabbit antihuman IgG (-y chain) serum (Behringwerke AG., Marburg-Lahn, W. Germany).
Complement studies: these were carried out on either EDTA-synovial fluid or EDTA-plasma. Hemolytic activity was quantitated in a continuous flow system (32), Clq, C4 and C3 were quantitated by single radial immunodiffusion as described earlier (33) . All values were expressed as a percentage of the values obtained with a pool of 30 blood donors, which was stored in liquid nitrogen. These values were corrected for a protein concentration of 70 mg/ml. Protein concentration was assayed by the method of Lowry et al. (34) .
Statistical evaluation. Statistical evaluation was carried out according to Student's t test and by linear regression analysis by the method of the least squares.
RESULTS
Clq-BA in synovial fluid and serum samples. The Clq-BA of synovial fluids from 149 patients with various joint diseases were studied. The patients were classified according to the clinical diagnoses: seropositive rheumatoid arthritis (RA +), seronegative rheumatoid arthritis (RA -), various other inflammatory arthritis (IA), degenerative joint disease (DJD) and post-traumatic joint effusion (TR). The synovial fluids of 15 patients with TR were used for the estimation of the nonspecific "I-Clq precipitation. The mean values for specific Clq-BA in synovial fluids of the remaining four patient groups are listed in Table I . The following observations were made: (a) the mean Clq-BA was significantly increased in RA + and RA -as compared to DJD (P <0.0005) and to IA (P <0.0005); (b) there was no significant difference in synovial fluid Clq-BA between RA + and RA -(P < 0.1); and (c) the mean Clq-BA in IA was significantly increased when compared to DJD (P <0.025). The values for Clq-BA in synovial fluids of individual patients are shown on Fig.  2 . When compared to DJD the synovial fluid Clq-BA was increased by more than 2 SD in 80% of patients with RA +, 71% with RA -, 29% with IA, and 0% with DJD. With respect to the IA group, it should be mentioned that the values were increased by more than 2 SD in three out of seven patients with infectious arthritis, two out of seven patients with gout, in a single patient with chondrocalcinosis, and in one of two patients with Reiter's disease. Synovial fluids from seven patients with RA + or RA -were obtained on the same day from both knee joints. The mean Clq-BA was the same for the right side joints (49±28%) and the left side joints (49±25%), and the mean individual difference between the right and the left knee joints was 6±4% (mean+l1 SD).
The sera from the patients who underwent synovial fluid analysis were also tested. 30 sera from healthy blood donors were used for the estimation of nonspecific 12I-Clq precipitation in serum. The mean values for specific serum Clq-BA in the various patient groups are also listed in Table I . The following observations were made: (a) the mean Clq-BA in serum was significantly increased in RA + and in RA -when compared to DJD (P <0.0005) and to IA (P <0.0005); (b) the mean serum Clq-BA was significantly higher in RA + than in RA -(P < 0.0005). One should note that such a difference was not observed in synovial fluid; and (c) the mean serum Clq-BA was not increased in the IA peared that a high mean Clq-BA was associated with a significant decrease of the mean hemolytic complement activity (P < 0.025) and C4 (P < 0.0005) in RA + and with a significant decrease of C4 in RA -(P < 0.0005).
In contrast, a low mean Clq-BA was associated with normal (DJD and TR) or even increased (IA) complement levels. Linear regression analysis gave significant negative correlations for Clq-BA and C4 levels in synovial fluids of patients with both RA + (P < 0.001) and RA -(P < 0.01) (Fig. 5) Clq-BA (%) FIGURE 5 Correlation between C4 levels and patients with RA+ and RA-.
fluids tested (Table III) . The 12 synovial fluids with elevated Clq-BA were also subjected to reduction with 0.2 M 2-mercaptoethanol and alkylation with iodoacetamide. This treatment completely abolished the Clq-BA of the synovial fluids (Table III) . The same treatment led to a decrease in Clq-BA of agg HGG in NHS 560C (0.5 mg/ml) from 50 to 17%. In order to investigate the size of Clq binding material, synovial fluids and sera from 20 patients with RA + and RA -, exhibiting a high Clq-BA, were subjected to ultracentrifugation analysis, using sucrose density gradients (10-40% wt/vol). For comparison, the respective materials from 10 patients with DJD and from 4 blood donors (NHS) were also analyzed. After ultracentrifugation, the Clq-BA was measured in each of seven serial gradient fractions. In experiments using synovial fluids from RA patients, Clq-BA was always encountered in gradient fractions one to four from the IgG was found to be located in the 14S peak, whereas at pH 3.8 the maximum was found to be located in the 7S peak. Immunoelectrophoretic analysis of this 7S peak fraction with antiserum to total human serum revealed only IgG. Secondly, the concentrated Clq binding material was left to react in an immunoabsorbant system. Small columns of CNBr-sepharose 4B coupled with rabbit antihuman IgG or with bovine serum albumin were used. Concentrated Clq binding material from RA synovial fluid was passed through these columns and the Clq-BA of the effluents were compared. Clq-BA was still observed in the effluent of the bovine serum albumin sepharose columns, while the effluent of the antiIgG sepharose columns no longer exhibited Clq binding activity. crose density gradients. This procedure led to a three to four times increased Clq-BA in 14-24S gradient fractions when compared to the Clq-BA in respective gradient fractions obtained by centrifugation of the original untreated synovial fluids. A representative experiment is shown on Fig. 8 Immune Complexes in Rheumatoid Arthritis The purpose of the present study was to investigate on a quantitative basis the incidence of immune complexes in serum and in synovial fluids from patients with RA, using a newly developed methodology which allowed for a sensitive detection of such immune complexes. As with the Clq precipitation test described by Agnello et al. (36) , the radioimmunoassay used in this investigation is based on the higher avidity of Clq for aggregated or complexed immunoglobulins as compared with monomeric immunoglobulins (37) . However, the sensitivity of the method has been increased by a direct measurement of the binding of Clq by immune complexes rather than by observing a secondary precipitation of those complexes by Clq. This procedure also largely avoided the possible interference of some substances which can nonspecifically fix Clq, such as DNA, bacterial lipopolysaccharides (22) , or calcium-dependent C reactive protein complexes (38) . However, one cannot a priori rule out the possibility that other substances with similar properties may influence these studies.
The results obtained confirm the existence of large amounts of immune complex-like material in synovial fluids from patients with RA. Indeed, the Clq-BA was significantly increased in those fluids when compared to the Clq-BA observed in samples from patients with DJD or with TR. The physicochemical characterization of the Clq binding material showed that it was similar to the 1O-30S macromolecular complexes observed in such fluids by ultracentrifugation analysis (3) (4) (5) 14) . Furthermore, the fact that this material lost its ability to bind Clq after acid dissociation or reduction-alkylation (39) tration of about 0.5 mg/ml (22) . However, this value should be considered as approximate, since the size and the nature of the detected complexes influence their efficiency to bind Clq (37) . It has been found previously that IgG-anti-IgG complexes can exhibit a higher Clq-BA than a similar amount of heat-aggregated IgG (21) .
The participation of 19S rheumatoid factor (RF) in the Clq binding complexes seemed relatively limited since (a) fluids from patients with RA -exhibited similar levels of Clq-BA to those from patients with RA +, and (b) the maximum Clq binding material by sucrose density gradient analysis was most frequently observed in the 14-15S range. An increased Clq-BA was also observed in synovial fluids from some patients with various IA. Although bacterial antigen-antibody complexes may be responsible for this binding in infectious arthritis, the occurrence of an increased Clq-BA in gout or chondrocalcinosis may correspond to a nonspecific aggregation of IgG in synovial fluids.
The investigation of immune complexes in serum from patients wtih RA led to some discrepancies according to various methods which had been previously used.
While 57% of RA + reacted with monoclonal RF, none of these sera precipitated with Clq in agarose (5). Recently, using a radioimmunoassay with monoclonal RF, Luthra, et al. (19) detected complexes in 24% of RA sera while in a similar assay, but using polyclonal RF, none of the RA sera studied exhibited a positive reaction (18) . Cryoglobulins were also found in 25% of sera (17) . In the present study, Clq binding material was found in 76% of RA + sera and in 49% of RAsera. The differences observed between the results obtained in these various studies probably indicate differences in the sensitivity of the methods used for the particular complexes present in RA sera or in the susceptibility of each technique to the interfering effect of RF. This was apparent when the method using the inhibition of the uptake of labeled agg HGG by macrophages was applied to RA sera (20) .
Using the Clq binding test, the main finding was that an increased Clq-BA in serum was observed frequently in both RA + and RA -patients but occurred only exceptionally in other IA. This result suggests that RA is a disease associated with circulating as well as articular immune complexes, while other IA may be associated with complexes formed in the joint spaces but rarely with circulating complexes. The size of the material binding Clq in RA sera is similar to that of the complexes which were detected with monoclonal rheumatoid factors (5) . It corresponds mostly to 15-20S intermediate complexes and may represent IgG-anti-IgG complexes. However, some larger complexes were also found in these serum samples. One cannot exclude the possibility that other antigen-antibody systems may be also responsible for the increase in Clq-BA in RA. The criteria for seropositivity with respect to rheumatoid factor was a positive sheep cell agglutination titer of 1:64 or higher. This is arbitrary and therefore some seronegative patients' sera may indeed have had a low IgM RF agglutinating activity. Moreover, it is well known that such "seronegative" patients usually exhibit the presence of IgG RF.
The studies of the correlation between Clq-BA and other biological features of RA indicated that the presence of immune complexes is not directly related to the concentration of RF 
